Prot #CBI-2019-RVS-DDCM: Evaluation of Clinical Outcomes in Patients with Cutaneous Melanocytic Lesions Tested with a Differential Diagnostic Gene Expression Assay

Project: Research project

Project Details

StatusActive
Effective start/end date2/3/202/3/23

Funding

  • Castle Biosciences, Inc. (Prot #CBI-2019-RVS-DDCM)